Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib was effective in treating hair loss in adults with alopecia areata according to patient feedback.

New itaconate prodrugs improve its absorption and effectiveness for treating inflammation.

Compounds from Pterocarpus indicus may help treat benign prostatic hyperplasia by stopping cell growth.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

Peps help Arabidopsis plants grow more root hairs by affecting specific genes and calcium signaling.

A genetic mutation in the LIPH gene causes a rare hair disorder with sparse, curly hair.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

Pembrolizumab can cause serious liver issues, requiring close monitoring and early treatment.

Total glucosides of paeony may help treat alopecia areata by reducing inflammation and hair loss.

Lysophosphatidic acid affects sensory neurons and may cause neuropathic pain and itch.

A new genetic variant in the LIPH gene causes hair growth issues in a Chinese patient.

Acitretin moderately improved skin and eye issues but not hair loss or light sensitivity in a 3-year-old with IFAP syndrome.

A man developed oral hairy leukoplakia while on baricitinib, a medication for alopecia and arthritis, and doctors should watch for such side effects.

A specific gene change is linked to severe hair loss.

Lichen planopilaris can cause hair loss on limbs, not just the scalp.

Chinese patients with alopecia areata value JAK inhibitors but worry about side effects and relapse, highlighting the need for education and support.

Baricitinib shows promise in improving frontal fibrosing alopecia symptoms.

A new mutation in the MBTPS2 gene causes a mild form of IFAP syndrome.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

The new delivery system improves treatment for hair loss by enhancing drug absorption and effectiveness.

Most European physicians know the risks and safe use of Cyproterone acetate, but few remember receiving official safety communications.